BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18034775)

  • 1. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.
    Fasen K; Cerretti DP; Huynh-Do U
    Traffic; 2008 Feb; 9(2):251-66. PubMed ID: 18034775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor.
    Rodriguez S; Huynh-Do U
    FASEB J; 2013 Feb; 27(2):632-44. PubMed ID: 23118026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells.
    Sharfe N; Freywald A; Toro A; Roifman CM
    J Immunol; 2003 Jun; 170(12):6024-32. PubMed ID: 12794130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118.
    Vindis C; Teli T; Cerretti DP; Turner CE; Huynh-Do U
    J Biol Chem; 2004 Jul; 279(27):27965-70. PubMed ID: 15107421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
    Masson K; Heiss E; Band H; Rönnstrand L
    Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
    Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
    Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
    Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
    Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced downregulation of TrkA is partly regulated through ubiquitination by Cbl.
    Takahashi Y; Shimokawa N; Esmaeili-Mahani S; Morita A; Masuda H; Iwasaki T; Tamura J; Haglund K; Koibuchi N
    FEBS Lett; 2011 Jun; 585(12):1741-7. PubMed ID: 21570973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.
    Vihanto MM; Vindis C; Djonov V; Cerretti DP; Huynh-Do U
    J Cell Sci; 2006 Jun; 119(Pt 11):2299-309. PubMed ID: 16723736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.
    Sun J; Pedersen M; Bengtsson S; Rönnstrand L
    Exp Cell Res; 2007 Nov; 313(18):3935-42. PubMed ID: 17904548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
    Mukhopadhyay C; Triplett A; Bargar T; Heckman C; Wagner KU; Naramura M
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8228-E8237. PubMed ID: 27930322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.
    Vindis C; Cerretti DP; Daniel TO; Huynh-Do U
    J Cell Biol; 2003 Aug; 162(4):661-71. PubMed ID: 12925710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy.
    Schmidt JF; Agapova OA; Yang P; Kaufman PL; Hernandez MR
    Br J Ophthalmol; 2007 Sep; 91(9):1219-24. PubMed ID: 17301119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.
    Rush JS; Boeving MA; Berry WL; Ceresa BP
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4691-9. PubMed ID: 24985478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.
    Huynh-Do U; Vindis C; Liu H; Cerretti DP; McGrew JT; Enriquez M; Chen J; Daniel TO
    J Cell Sci; 2002 Aug; 115(Pt 15):3073-81. PubMed ID: 12118063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphB1 associates with Grb7 and regulates cell migration.
    Han DC; Shen TL; Miao H; Wang B; Guan JL
    J Biol Chem; 2002 Nov; 277(47):45655-61. PubMed ID: 12223469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.